Laboratorio Farmaceutico Erfo Logo

Laboratorio Farmaceutico Erfo

Full-service contract manufacturer of private label supplements and medical devices.

ERFO | XMIL

Overview

Corporate Details

ISIN(s):
IT0005497836 (+1 more)
LEI:
8945005CB564D0OBQQ85
Country:
Italy
Address:
VIALE GEKI RUSSO, SNC (PONTE GALLO), 98049 VILLAFRANCA TIRRENA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Laboratorio Farmaceutico Erfo S.p.A. is an innovative company specializing in the nutraceutical sector. The firm provides contract manufacturing services for food supplements and medical devices, offering a comprehensive, end-to-end solution for third-party brands. Its services span the entire product development lifecycle, from formulation and raw material selection to production, packaging design, and legal consulting. Operating from a modern, ISO 9001:2015 certified facility authorized by the Italian Ministry of Health, Erfo supports clients with both small-batch and large-scale production runs for private label products. The company manufactures various pharmaceutical forms, including capsules, tablets, sachets, vials, and bottles. Erfo is a registered Benefit Corporation (Società Benefit).

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 07:27
Regulatory Filings
Laboratorio Farmaceutico Erfo S.p.A. - Comunicazione dati gestionali IIIQ 2025
Italian 696.9 KB
2025-11-11 08:24
Remuneration Information
Laboratorio Farmaceutico Erfo S.p.A. - Approvazione regolamento attuativo piano…
Italian 410.6 KB
2025-10-17 08:00
Regulatory Filings
ERFO parteciperà alla sesta edizione della conferenza "NEXT GEMS"
Italian 453.6 KB
2025-10-15 19:00
Remuneration Information
Laboratorio Farmaceutico Erfo S.p.A. - Assemblea approva piano di incentivazion…
Italian 403.6 KB
2025-09-30 17:09
Pre-Annual General Meeting Information
Laboratorio Farmaceutico Erfo S.p.A. - Pubblicazione Avviso di Convocazione e d…
Italian 450.0 KB
2025-09-27 16:21
Earnings Release
Laboratorio Farmaceutico Erfo S.p.A. - Approvazione relazione semestrale consol…
Italian 1.5 MB
2025-08-28 18:09
Earnings Release
Laboratorio Farmaceutico Erfo S.p.A.: 1H 2025 financial figures
English 502.5 KB
2025-08-28 13:00
Earnings Release
Laboratorio Farmaceutico Erfo S.p.A. - Comunicazione dati gestionali IH 2025
Italian 334.1 KB
2025-08-20 23:05
Director's Dealing
Comunicazione internal dealing
Italian 87.4 KB
2025-08-09 11:14
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 377.2 KB
2025-08-02 09:19
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 375.9 KB
2025-07-25 20:05
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 374.5 KB
2025-07-18 20:04
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 377.1 KB
2025-07-12 09:39
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 375.4 KB
2025-07-04 18:21
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 373.3 KB

Automate Your Workflow. Get a real-time feed of all Laboratorio Farmaceutico Erfo filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Laboratorio Farmaceutico Erfo

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Laboratorio Farmaceutico Erfo via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CKD Bio Corp. Logo
Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.
South Korea
063160
Clearmind Medicine Inc. Logo
Develops psychedelic-derived medicines for Alcohol Use Disorder and mental health conditions.
United States of America
CMND
Clearside Biomedical, Inc. Logo
Developing therapies for back-of-the-eye diseases via proprietary suprachoroidal delivery.
United States of America
CLSD
Clene Inc. Logo
Developing nanocrystal therapies for neurodegenerative diseases like ALS and MS.
United States of America
CLNN
CMG Pharmaceutical Co., Ltd. Logo
Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.
South Korea
058820
CNS Pharmaceuticals, Inc. Logo
Biotech developing drugs that cross the blood-brain barrier for brain and CNS cancers.
United States of America
CNSP
Cocrystal Pharma, Inc. Logo
Develops novel antiviral drugs for influenza, coronaviruses, norovirus, and hepatitis C.
United States of America
COCP
Co-Diagnostics, Inc. Logo
Develops patented PCR solutions for accurate infectious disease diagnostics.
United States of America
CODX
co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany
CNW
Coeptis Therapeutics Holdings, Inc. Logo
Develops cell therapy platforms for cancer, autoimmune, and infectious diseases.
United States of America
COEP

Talk to a Data Expert

Have a question? We'll get back to you promptly.